Palisade Bio (PALI) Other Working Capital Changes (2010 - 2026)
Palisade Bio's (PALI) quarterly Other Working Capital Changes came in at $127000.0 in Q3 2025, up 496.88% year-on-year from $21277.5 in Q3 2024, and up 473.53% on a QoQ basis from -$34000.0 in Q2 2025.
Palisade Bio (PALI) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Palisade Bio (PALI) has 13 years of Other Working Capital Changes data on file, last reported at $127000.0 in Q3 2025.
- On a quarterly basis, Other Working Capital Changes rose 496.88% year-over-year to $127000.0 in Q3 2025; TTM through Mar 2026 was $93000.0, a 2425.0% increase from a year earlier, with the FY2025 full-year figure at $61000.0, changed N/A from the prior year.
- Other Working Capital Changes for Q3 2025 stood at $127000.0, up from -$34000.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for PALI reached as high as $519000.0 in Q3 2025 and fell as low as -$1.1 million in Q4 2025.
- Historically, Other Working Capital Changes has averaged -$178411.8 across 5 years, with a median of -$175000.0 in 2024.
- Across the five-year window, Other Working Capital Changes plunged 1682.61% in 2022 and jumped 496.88% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at $23000.0 in 2021, then plunged by 1682.61% to -$364000.0 in 2022, then jumped by 143.41% to $158000.0 in 2023, then sank by 43.67% to $89000.0 in 2024, then soared by 42.7% to $127000.0 in 2025.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were $127000.0 in Q3 2025, -$34000.0 in Q2 2025, and -$32000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22,000.00 |
| Mar 31, 2026 | -22,000.00 |
| Mar 31, 2026 | -22,000.00 |
| Dec 31, 2025 | -1.07 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Sep 30, 2025 | 519,000.00 |
| Sep 30, 2025 | 519,000.00 |
| Sep 30, 2025 | 519,000.00 |
| Jun 30, 2025 | 85,000.00 |
| Jun 30, 2025 | 85,000.00 |
| Jun 30, 2025 | 85,000.00 |
| Mar 31, 2025 | -67,000.00 |
| Mar 31, 2025 | -67,000.00 |
| Mar 31, 2025 | -67,000.00 |
| Dec 31, 2024 | -208,000.00 |
| Dec 31, 2024 | -208,000.00 |
| Dec 31, 2024 | -208,000.00 |
| Sep 30, 2024 | -193,000.00 |
| Sep 30, 2024 | -193,000.00 |